Something to ponder for another day with no news.
This started in November when Brandon Rae came back to Cytodyn from Qilu.
Money was becoming a much larger concern and the time was right to be aggressive about a partner.
By the new year they were already in partnership talks because Qilu (or others) were interested in either Nash or Cancer, the two areas management has discussed partnerships for AND the two areas we were getting exciting new data from.
This is exactly why Rae was rehired.
Then whoever was looking under the hood for the odd-fire V6 they expected, instead found a donkey-stomping hemi with solid gold mounts. When they looked back up, mouths agape, they, for the first time, noticed the show quality CJ8 and FJ40 at the back of the garage. Now a canning the entire facility, they see something close to 60 very valuable vehicles scattered about, each worth more than the last. And that’s when they realize they’re looking at something far more valuable than they’d thought. Time to shift gears.
Just prior to the conference call they decide to make an offer for the whole company, requiring silence out of management as they hash things out. Don’t release Nash, don’t say a word. Even to Figgs or CDiddy.
Nader, knowing he’s no longer needed, agrees to a termination package. Or he wanted a larger number from the buyer and the board knew they needed him out of the way to get things done. Doesn’t really matter how it went down. He wouldn’t be needed for this and he wouldn’t be needed after. He was never sticking around once it got to this point.
Now we’re just waiting to find out how much it’ll be for and then we vote.
It’ll pass as long as it’s a decent number.
And even if it doesn’t we’d see the share price rise toward that number and our new leaders wouldn’t be dumb enough to not raise money. At which point we’d have plenty of money for trials and we’d still be able to sign a partnership agreement.
This is all just a wild ass guess, but it doesn’t not make sense, right?
People think it don’t be like it is, but it do.
This started in November when Brandon Rae came back to Cytodyn from Qilu.
Money was becoming a much larger concern and the time was right to be aggressive about a partner.
By the new year they were already in partnership talks because Qilu (or others) were interested in either Nash or Cancer, the two areas management has discussed partnerships for AND the two areas we were getting exciting new data from.
This is exactly why Rae was rehired.
Then whoever was looking under the hood for the odd-fire V6 they expected, instead found a donkey-stomping hemi with solid gold mounts. When they looked back up, mouths agape, they, for the first time, noticed the show quality CJ8 and FJ40 at the back of the garage. Now a canning the entire facility, they see something close to 60 very valuable vehicles scattered about, each worth more than the last. And that’s when they realize they’re looking at something far more valuable than they’d thought. Time to shift gears.
Just prior to the conference call they decide to make an offer for the whole company, requiring silence out of management as they hash things out. Don’t release Nash, don’t say a word. Even to Figgs or CDiddy.
Nader, knowing he’s no longer needed, agrees to a termination package. Or he wanted a larger number from the buyer and the board knew they needed him out of the way to get things done. Doesn’t really matter how it went down. He wouldn’t be needed for this and he wouldn’t be needed after. He was never sticking around once it got to this point.
Now we’re just waiting to find out how much it’ll be for and then we vote.
It’ll pass as long as it’s a decent number.
And even if it doesn’t we’d see the share price rise toward that number and our new leaders wouldn’t be dumb enough to not raise money. At which point we’d have plenty of money for trials and we’d still be able to sign a partnership agreement.
This is all just a wild ass guess, but it doesn’t not make sense, right?
People think it don’t be like it is, but it do.
28
